MyTomorrows CEO and CoFounder Ronald Brus
This is great news for MyTomorrows, who are continuing their mission to save lives, by enabling patients with unmet medical needs to access clinical trials and early access programmes. The company is now active in 17 countries and will use this funding to accelerate their own investment in technology and talent.
Sign up for our newsletter to stay up to date on news from Balderton, and our portfolio.